Powered by Smartsupp

Science Corp Launches $400M Series D at $3.5B Valuation to Advance Brain-Computer Interface Technology



By admin | Nov 17, 2026 | 1 min read


Science Corp Launches $400M Series D at $3.5B Valuation to Advance Brain-Computer Interface Technology

Science Corporation, a medical technology startup established in 2021 by Max Hodak—the former president of Neuralink—has raised $400 million in a Series D round, according to a company blog post. The new investors valued the company at $3 [billion]. Backers in this round included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech.

Hodak, who talked his way into a graduate neuroscience lab as a college student and has pursued biotechnology ever since, co-founded Science to leverage new technologies to understand and interact with the brain. Science's first product is PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision. The device is approved in Europe and available in Germany, as well as being trialled for new conditions.

With the funding, the company aims to bring the device to the United States through the FDA's Humanitarian Device Exemption, which lets experimental medical technology be used to treat rare conditions. Science has convinced the FDA that advanced macular degeneration in both eyes is uncommon enough to let them seek approval to use the device on people in the US. Still, the startup's big ambition and founding purpose is connecting directly to the human brain through a bio-hybrid sensor built from a combination of cultured neurons and silicon.




RELATED AI TOOLS CATEGORIES AND TAGS

Comments

Please log in to leave a comment.

No comments yet. Be the first to comment!